RAPS: DA Begins Process of Overhauling Off-Label Communications Regulations

08.09.2016

The US Food and Drug Administration (FDA) on Wednesday announced a new two-day public meeting to address a comprehensive review of its regulations and policies governing firms’ off-label communications on unapproved uses of approved drugs and medical devices.